LYPLA2 Antibodies

Santa Cruz Biotechnology features a diverse variety of LYPLA2 monoclonal antibodies for investigating lysophospholipase 2 (LYPLA2) in biological processes. LYPLA2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LYPLA2 is an essential enzyme that catalyzes the hydrolysis of lysophospholipids, playing key roles in cell signaling and membrane dynamics. The regulation of LYPLA2 activity maintains cellular homeostasis and influences various physiological processes. Research has shown LYPLA2's involvement in inflammation and cancer development. Investigating LYPLA2 function continues to reveal new possibilities for therapeutic interventions. Understanding the mechanisms of LYPLA2 advances knowledge in lipid biology and its impact on human health. LYPLA2 research using Santa Cruz Biotechnology monoclonal antibodies contributes to scientific discoveries that may lead to innovative therapeutic strategies.